STC1: Difference between revisions
mNo edit summary |
m (Bot: HTTP→HTTPS) |
||
(One intermediate revision by one other user not shown) | |||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
{{ | '''Stanniocalcin-1''' is a [[glycoprotein]], a homologue of a hormone [[stanniocalcin]], first discovered in bony fishes. In humans it is encoded by the ''STC1'' [[gene]].<ref name="pmid9480753">{{cite journal | vauthors = Chang AC, Jeffrey KJ, Tokutake Y, Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y, Reddel RR | title = Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats | journal = Genomics | volume = 47 | issue = 3 | pages = 393–8 | date = Feb 1998 | pmid = 9480753 | pmc = | doi = 10.1006/geno.1997.5120 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: STC1 stanniocalcin 1| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=6781| accessdate = }}</ref> | ||
| | |||
| | |||
| | |||
| | |||
| | |||
}} | |||
== Function == | |||
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. Human Stanniocalcin-1 is a putative molecular biomarker of leukemic microenvironment and the only molecular function known up to date is a SUMO E3 ligase activity in the SUMOylation cycle. STC1 interacts with lots of proteins in the [[cytoplasm]], [[mitochondria]], endoplasmatic [[reticulum]] and dot-like fashion in the nucleus. The N-terminal region of STC1 is the function region which is responsible to establish the interaction with its partners, including SUMO1.<ref>{{cite journal | vauthors = dos Santos MT, Trindade DM, Gonçalves Kde A, Bressan GC, Anastassopoulos F, Yunes JA, Kobarg J | title = Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase | journal = Molecular bioSystems | volume = 7 | issue = 1 | pages = 180–93 | date = Jan 2011 | pmid = 21042649 | doi = 10.1039/c0mb00088d }}</ref> Low resolution studies shows that STC1 is an anti-parallel homodimer in solution and the cystein 202 is responsible for the dimerization of this protein. All the 5 dissulfide bonds of human STC1 are conserved and has the same profile of fish STC.<ref>{{cite journal | vauthors = Trindade DM, Silva JC, Navarro MS, Torriani IC, Kobarg J | title = Low-resolution structural studies of human Stanniocalcin-1 | journal = BMC Structural Biology | volume = 9 | pages = 57 | date = Aug 27, 2009 | pmid = 19712479 | pmc = 2744999 | doi = 10.1186/1472-6807-9-57 }}</ref> The gene contains a 5' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved [[cysteine]] residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate [[homeostasis]]. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, [[dwarfism]], and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers.<ref name="entrez"/> | |||
==References== | == References == | ||
{{reflist}} | {{reflist}} | ||
==Further reading== | |||
== Further reading == | |||
{{refbegin | 2}} | {{refbegin | 2}} | ||
* {{cite journal | vauthors = Chang AC, Jellinek DA, Reddel RR | title = Mammalian stanniocalcins and cancer | journal = Endocrine-Related Cancer | volume = 10 | issue = 3 | pages = 359–73 | date = Sep 2003 | pmid = 14503913 | doi = 10.1677/erc.0.0100359 }} | |||
* {{cite journal | vauthors = Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB | title = Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells | journal = Cancer Research | volume = 52 | issue = 24 | pages = 6966–8 | date = Dec 1992 | pmid = 1458489 | doi = }} | |||
*{{cite journal | * {{cite journal | vauthors = Chang AC, Janosi J, Hulsbeek M, de Jong D, Jeffrey KJ, Noble JR, Reddel RR | title = A novel human cDNA highly homologous to the fish hormone stanniocalcin | journal = Molecular and Cellular Endocrinology | volume = 112 | issue = 2 | pages = 241–7 | date = Aug 1995 | pmid = 7489828 | doi = 10.1016/0303-7207(95)03601-3 }} | ||
*{{cite journal | * {{cite journal | vauthors = Wagner GF, Guiraudon CC, Milliken C, Copp DH | title = Immunological and biological evidence for a stanniocalcin-like hormone in human kidney | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 92 | issue = 6 | pages = 1871–5 | date = Mar 1995 | pmid = 7892193 | pmc = 42384 | doi = 10.1073/pnas.92.6.1871 }} | ||
*{{cite journal | * {{cite journal | vauthors = Olsen HS, Cepeda MA, Zhang QQ, Rosen CA, Vozzolo BL, Wagner GF | title = Human stanniocalcin: a possible hormonal regulator of mineral metabolism | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 93 | issue = 5 | pages = 1792–6 | date = Mar 1996 | pmid = 8700837 | pmc = 39860 | doi = 10.1073/pnas.93.5.1792 }} | ||
*{{cite journal | * {{cite journal | vauthors = Zhang KZ, Westberg JA, Paetau A, von Boguslawsky K, Lindsberg P, Erlander M, Guo H, Su J, Olsen HS, Andersson LC | title = High expression of stanniocalcin in differentiated brain neurons | journal = The American Journal of Pathology | volume = 153 | issue = 2 | pages = 439–45 | date = Aug 1998 | pmid = 9708804 | pmc = 1852984 | doi = 10.1016/S0002-9440(10)65587-3 }} | ||
*{{cite journal | * {{cite journal | vauthors = Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE | title = Comparative analysis of mammalian stanniocalcin genes | journal = Endocrinology | volume = 139 | issue = 11 | pages = 4714–25 | date = Nov 1998 | pmid = 9794484 | doi = 10.1210/en.139.11.4714 }} | ||
* {{cite journal | vauthors = ((Zhang Kz)), Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC | title = Stanniocalcin: A molecular guard of neurons during cerebral ischemia | journal = Proceedings of the National Academy of Sciences of the United States of America | volume = 97 | issue = 7 | pages = 3637–42 | date = Mar 2000 | pmid = 10725397 | pmc = 16292 | doi = 10.1073/pnas.070045897 }} | |||
*{{cite journal | * {{cite journal | vauthors = Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR | title = Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells | journal = The Biochemical Journal | volume = 350 Pt 2 | issue = 2 | pages = 453–61 | date = Sep 2000 | pmid = 10947959 | pmc = 1221272 | doi = 10.1042/0264-6021:3500453 }} | ||
*{{cite journal | * {{cite journal | vauthors = Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE | title = Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice | journal = Endocrinology | volume = 143 | issue = 3 | pages = 868–76 | date = Mar 2002 | pmid = 11861508 | doi = 10.1210/en.143.3.868 }} | ||
*{{cite journal | * {{cite journal | vauthors = McCudden CR, James KA, Hasilo C, Wagner GF | title = Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism | journal = The Journal of Biological Chemistry | volume = 277 | issue = 47 | pages = 45249–58 | date = Nov 2002 | pmid = 12223480 | doi = 10.1074/jbc.M205954200 }} | ||
*{{cite journal | * {{cite journal | vauthors = Serlachius M, Alitalo R, Olsen HS, Andersson LC | title = Expression of stanniocalcin-1 in megakaryocytes and platelets | journal = British Journal of Haematology | volume = 119 | issue = 2 | pages = 359–63 | date = Nov 2002 | pmid = 12406069 | doi = 10.1046/j.1365-2141.2002.03916.x }} | ||
*{{cite journal | * {{cite journal | vauthors = Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, Poindexter B, Taegtmeyer H, Wamsley A, Padda R, Entman M, Nielsen S, Youker K | title = Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure | journal = American Journal of Physiology. Heart and Circulatory Physiology | volume = 285 | issue = 1 | pages = H442-8 | date = Jul 2003 | pmid = 12663264 | doi = 10.1152/ajpheart.01071.2002 }} | ||
*{{cite journal | * {{cite journal | vauthors = Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV, Gerritsen ME | title = Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor | journal = The Journal of Biological Chemistry | volume = 278 | issue = 48 | pages = 47654–9 | date = Nov 2003 | pmid = 14500721 | doi = 10.1074/jbc.M301353200 }} | ||
*{{cite journal | * {{cite journal | vauthors = McCudden CR, Majewski A, Chakrabarti S, Wagner GF | title = Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas | journal = Molecular and Cellular Endocrinology | volume = 213 | issue = 2 | pages = 167–72 | date = Jan 2004 | pmid = 15062564 | doi = 10.1016/j.mce.2003.10.042 }} | ||
* {{cite journal | vauthors = Luo CW, Kawamura K, Klein C, Hsueh AJ | title = Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors | journal = Molecular Endocrinology | volume = 18 | issue = 8 | pages = 2085–96 | date = Aug 2004 | pmid = 15131261 | doi = 10.1210/me.2004-0066 }} | |||
*{{cite journal | * {{cite journal | vauthors = Serlachius M, Andersson LC | title = Upregulated expression of stanniocalcin-1 during adipogenesis | journal = Experimental Cell Research | volume = 296 | issue = 2 | pages = 256–64 | date = Jun 2004 | pmid = 15149855 | doi = 10.1016/j.yexcr.2004.02.016 }} | ||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
*{{cite journal | |||
}} | |||
{{refend}} | {{refend}} | ||
{{ | |||
{{gene-8-stub}} |
Latest revision as of 07:10, 11 September 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
Stanniocalcin-1 is a glycoprotein, a homologue of a hormone stanniocalcin, first discovered in bony fishes. In humans it is encoded by the STC1 gene.[1][2]
Function
This gene encodes a secreted, homodimeric glycoprotein that is expressed in a wide variety of tissues and may have autocrine or paracrine functions. Human Stanniocalcin-1 is a putative molecular biomarker of leukemic microenvironment and the only molecular function known up to date is a SUMO E3 ligase activity in the SUMOylation cycle. STC1 interacts with lots of proteins in the cytoplasm, mitochondria, endoplasmatic reticulum and dot-like fashion in the nucleus. The N-terminal region of STC1 is the function region which is responsible to establish the interaction with its partners, including SUMO1.[3] Low resolution studies shows that STC1 is an anti-parallel homodimer in solution and the cystein 202 is responsible for the dimerization of this protein. All the 5 dissulfide bonds of human STC1 are conserved and has the same profile of fish STC.[4] The gene contains a 5' UTR rich in CAG trinucleotide repeats. The encoded protein contains 11 conserved cysteine residues and is phosphorylated by protein kinase C exclusively on its serine residues. The protein may play a role in the regulation of renal and intestinal calcium and phosphate transport, cell metabolism, or cellular calcium/phosphate homeostasis. Overexpression of human stanniocalcin 1 in mice produces high serum phosphate levels, dwarfism, and increased metabolic rate. This gene has altered expression in hepatocellular, ovarian, and breast cancers.[2]
References
- ↑ Chang AC, Jeffrey KJ, Tokutake Y, Shimamoto A, Neumann AA, Dunham MA, Cha J, Sugawara M, Furuichi Y, Reddel RR (Feb 1998). "Human stanniocalcin (STC): genomic structure, chromosomal localization, and the presence of CAG trinucleotide repeats". Genomics. 47 (3): 393–8. doi:10.1006/geno.1997.5120. PMID 9480753.
- ↑ 2.0 2.1 "Entrez Gene: STC1 stanniocalcin 1".
- ↑ dos Santos MT, Trindade DM, Gonçalves Kde A, Bressan GC, Anastassopoulos F, Yunes JA, Kobarg J (Jan 2011). "Human stanniocalcin-1 interacts with nuclear and cytoplasmic proteins and acts as a SUMO E3 ligase". Molecular bioSystems. 7 (1): 180–93. doi:10.1039/c0mb00088d. PMID 21042649.
- ↑ Trindade DM, Silva JC, Navarro MS, Torriani IC, Kobarg J (Aug 27, 2009). "Low-resolution structural studies of human Stanniocalcin-1". BMC Structural Biology. 9: 57. doi:10.1186/1472-6807-9-57. PMC 2744999. PMID 19712479.
Further reading
- Chang AC, Jellinek DA, Reddel RR (Sep 2003). "Mammalian stanniocalcins and cancer". Endocrine-Related Cancer. 10 (3): 359–73. doi:10.1677/erc.0.0100359. PMID 14503913.
- Liang P, Averboukh L, Keyomarsi K, Sager R, Pardee AB (Dec 1992). "Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells". Cancer Research. 52 (24): 6966–8. PMID 1458489.
- Chang AC, Janosi J, Hulsbeek M, de Jong D, Jeffrey KJ, Noble JR, Reddel RR (Aug 1995). "A novel human cDNA highly homologous to the fish hormone stanniocalcin". Molecular and Cellular Endocrinology. 112 (2): 241–7. doi:10.1016/0303-7207(95)03601-3. PMID 7489828.
- Wagner GF, Guiraudon CC, Milliken C, Copp DH (Mar 1995). "Immunological and biological evidence for a stanniocalcin-like hormone in human kidney". Proceedings of the National Academy of Sciences of the United States of America. 92 (6): 1871–5. doi:10.1073/pnas.92.6.1871. PMC 42384. PMID 7892193.
- Olsen HS, Cepeda MA, Zhang QQ, Rosen CA, Vozzolo BL, Wagner GF (Mar 1996). "Human stanniocalcin: a possible hormonal regulator of mineral metabolism". Proceedings of the National Academy of Sciences of the United States of America. 93 (5): 1792–6. doi:10.1073/pnas.93.5.1792. PMC 39860. PMID 8700837.
- Zhang KZ, Westberg JA, Paetau A, von Boguslawsky K, Lindsberg P, Erlander M, Guo H, Su J, Olsen HS, Andersson LC (Aug 1998). "High expression of stanniocalcin in differentiated brain neurons". The American Journal of Pathology. 153 (2): 439–45. doi:10.1016/S0002-9440(10)65587-3. PMC 1852984. PMID 9708804.
- Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE (Nov 1998). "Comparative analysis of mammalian stanniocalcin genes". Endocrinology. 139 (11): 4714–25. doi:10.1210/en.139.11.4714. PMID 9794484.
- Zhang Kz, Lindsberg PJ, Tatlisumak T, Kaste M, Olsen HS, Andersson LC (Mar 2000). "Stanniocalcin: A molecular guard of neurons during cerebral ischemia". Proceedings of the National Academy of Sciences of the United States of America. 97 (7): 3637–42. doi:10.1073/pnas.070045897. PMC 16292. PMID 10725397.
- Jellinek DA, Chang AC, Larsen MR, Wang X, Robinson PJ, Reddel RR (Sep 2000). "Stanniocalcin 1 and 2 are secreted as phosphoproteins from human fibrosarcoma cells". The Biochemical Journal. 350 Pt 2 (2): 453–61. doi:10.1042/0264-6021:3500453. PMC 1221272. PMID 10947959.
- Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE (Mar 2002). "Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice". Endocrinology. 143 (3): 868–76. doi:10.1210/en.143.3.868. PMID 11861508.
- McCudden CR, James KA, Hasilo C, Wagner GF (Nov 2002). "Characterization of mammalian stanniocalcin receptors. Mitochondrial targeting of ligand and receptor for regulation of cellular metabolism". The Journal of Biological Chemistry. 277 (47): 45249–58. doi:10.1074/jbc.M205954200. PMID 12223480.
- Serlachius M, Alitalo R, Olsen HS, Andersson LC (Nov 2002). "Expression of stanniocalcin-1 in megakaryocytes and platelets". British Journal of Haematology. 119 (2): 359–63. doi:10.1046/j.1365-2141.2002.03916.x. PMID 12406069.
- Sheikh-Hamad D, Bick R, Wu GY, Christensen BM, Razeghi P, Poindexter B, Taegtmeyer H, Wamsley A, Padda R, Entman M, Nielsen S, Youker K (Jul 2003). "Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure". American Journal of Physiology. Heart and Circulatory Physiology. 285 (1): H442–8. doi:10.1152/ajpheart.01071.2002. PMID 12663264.
- Zlot C, Ingle G, Hongo J, Yang S, Sheng Z, Schwall R, Paoni N, Wang F, Peale FV, Gerritsen ME (Nov 2003). "Stanniocalcin 1 is an autocrine modulator of endothelial angiogenic responses to hepatocyte growth factor". The Journal of Biological Chemistry. 278 (48): 47654–9. doi:10.1074/jbc.M301353200. PMID 14500721.
- McCudden CR, Majewski A, Chakrabarti S, Wagner GF (Jan 2004). "Co-localization of stanniocalcin-1 ligand and receptor in human breast carcinomas". Molecular and Cellular Endocrinology. 213 (2): 167–72. doi:10.1016/j.mce.2003.10.042. PMID 15062564.
- Luo CW, Kawamura K, Klein C, Hsueh AJ (Aug 2004). "Paracrine regulation of ovarian granulosa cell differentiation by stanniocalcin (STC) 1: mediation through specific STC1 receptors". Molecular Endocrinology. 18 (8): 2085–96. doi:10.1210/me.2004-0066. PMID 15131261.
- Serlachius M, Andersson LC (Jun 2004). "Upregulated expression of stanniocalcin-1 during adipogenesis". Experimental Cell Research. 296 (2): 256–64. doi:10.1016/j.yexcr.2004.02.016. PMID 15149855.
This article on a gene on human chromosome 8 is a stub. You can help Wikipedia by expanding it. |